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Summary
Trypanosoma cruzi expresses a developmentally regulated neuraminidase (TCNA) implicated in
parasite invasion ofcells. We isolated full-length DNA clones encoding TCNA. Sequence analysis
demonstrated an open reading frame coding for a polypeptide of 1,162 amino acids. In the
N-terminus there is a cysteine-rich domain containing a stretch of 332 amino acids nearly 30%
identical to the Clostridium perfringens neuraminidase, three repeat motifs highly conserved in
bacterial and viral neuraminidases, and two segments with similarityto the YWTD repeats found
in the low density lipoprotein (LDL) receptor and in other vertebrate and invertebrate proteins.
This domain is connected by a structure characteristic of type III modules of fibronectin to a
long terminal repeat (LTR) consisting of 44 full length copies of twelve amino acids rich (75%)
in serine, threonine, and proline. LTR is unusual in that it contains at least 117 potential phos-
phorylation sites. At the extreme C-terminus is a hydrophobic segment of 35 amino acids, which
could mediate anchorage of TCNA to membranes via a glycosylphosphatidylinositol linkage.
This is the first time a protozoan protein has been found to contain a YWTD repeat and a fibronectin
type III module. The domain structure of TCNA suggests that the enzyme may have functions
additional to its catalytic activity such as in protein-protein interaction, which could play a role
in T. cruzi binding to host cells.
T
rypanosoma
￿
'cruzi causes Chagas disease, a chronic de-
bilitating, incurable disease that afflicts millions ofpeople
in Latin America. T, cruziexists in three developmental forms:
amastigotes and epimastigotes which are multiplying forms,
and trypomastigotes, which do not multiply but instead
transmit infection from insects to mammals, and vice-versa
(1). The molecular mechanism underlying trypomastigote-
host cell interaction is beginning to be understood, and it
appears that specific recognition molecules mediate T. cruzi
invasion of cells (2).
One protein suggested to play a role in T. cruzi-host cell
interaction is the parasite neuraminidase (TCNA)l (3, 4) .
Polyclonal and monoclonal antibodies raised against TCNA
enhance infection at concentrations that inhibit enzyme ac-
tivity (5, 6). Enhancement of infection is probably a conse-
quence ofreduced TCNA activity because it can be abrogated
Abbreviations used in this paper. BNR, bacterial neuraminidase; EGF,
epidermal growth factor; GPI, glycosylphosphatidylinositol; HDL, high
density lipoprotein; LDL, low density lipoprotein; LTR, long-terminal
repeat; ORF, open reading frame; SAPA, shed acute phase antigen; TCNA,
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by exogenous neuraminidase (e.g., Vibrio cholera), whose ac-
tivity is not inhibited by the TCNA antibodies (5, 6). T. cruzi
infection is also augmented by high density lipoprotein (HDL)
and low density lipoprotein (LDL), two inhibitors of TCNA
activity (7, 8). Enhancement of infection by HDL and LDL
is blocked by I! cholera neuraminidase, an enzyme that is not
inhibited by HDL or LDL. It is not clear how neutralization
of endogenous TCNA keeps T. cruzi infection in check, but
it seems that desialylation removes the receptor for the
trypomastigote adhesin (2) .
TCNA is developmentally regulated, with maximal activity
in trypomastigotes, minimum in epimastigotes, and not de-
tectable in amastigotes (3, 4). The enzyme is located on the
surface ofthe parasite (9, 10) where it can chemically modify,
by desialylation, the surfaces of myocardial and vascular en-
dothelial cells (11), and of erythrocytes (12). After transfor-
mation from amastigotes intracellularly, all trypomastigotes
express neuraminidase (i.e., they are of the NA' phenotype),
as they do upon exiting ruptured host cells into the culture
medium (13) . Once in the extracellular millieu, NA' try-
pomastigotes differentiate into NA - trypomastigotes (i.e.,
parasites that do not express enzyme activity) to reach an
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-80% is NA- (3).
TCNA is highly polymorphic. The enzyme from metacy-
clic trypomastigotes has an apparent molecular weight of
66,000 (14), as does the NA from epimastigotes (Rosenberg,
I., R.P. Prioli, and M.E.A. Pereira, unpublished observation),
and, as assessed by immunoblotting using mono- and poly-
clonal antibodies, the TCNA from tissue culture trypo-
mastigotes consists of a set of apparently glycosylated poly-
peptides whose range in size depends on the strain or clone
analyzed (6). For example, in the Silvio X-10/4 clone, the
enzyme is comprised of bands of apparent mol wt 120,000,
160,000, and a 200,000 doublet; and in the Y-H6 and MV-13
clones, TCNA is made up of bands ranging from 130,000
to 222,000. Under nondenaturing conditions, these polypep-
tides are held together as trimers by noncovalent bonds (Prioli,
R.P., J.S. Mejia, and M.E .A. Pereira, manuscript in prepa-
ration).
The primary structure of TCNA is unknown. Here we
report the isolation and sequencing of the DNA encoding
one of the TCNA isoforms from tissue culture trypomas-
tigotes. The deduced amino acid sequence reveals a catalytic
domain in the N-terminus, which is structurally similar to
bacterial neuraminidases, in particularthe Clostridiumperfringens
enzyme, that contains two YWTD sequence motifs; a do-
main similar to fibronectin III modules containing GTP-
binding consensus sequences; a long terminal tandem repeating
structure rich (75%) in serine, threonine and proline residues;
and, a hydrophobic stretch of 35 amino acids at the extreme
C-terminus which could mediate anchorage ofTCNAto the
cell surface by a glycosylphosphatidylinositol (GPI) linkage.
Materials and Methods
Parasites.
￿
All studies were performed with the cloned Silvio
X-10/4 and Montalvania-13 strains of T . cruzi (4). Epimastigotes
were grown in liver-infusion medium containing 10% FCS, and
trypomastigotes were propagated in Vero cells as previously de-
scribed (4, 11).
Antibodies.
￿
TCNA mAbs TCN-1 and TCN-2 were isolated from
mice infected with a clone of Montalvania-13 that expresses high
enzyme activity (4). These antibodiesinhibit neuraminidase activity
and deplete TCNA from trypornastigote lysates after addition of
protein A-Sepharose, and are specific for the TCNA from tissue
culture trypomastigotes, as they do not reactwith the enzyme from
epimastigotes.
Antibodies against 7F, a recombinant TCNA clone, were ob-
tained as a modification of our previously publishedprocedure (5).
Bacterial lysates containingrecombinant TCNA from 7F insert (see
below) were run on a 10% SDS-PAGE, the lanes in the right and
left corners cut out with a scalpel, blotted on nitrocellulose and
probed with TCN-2 to visualize the relative position of the TCN-2
immunoreactive protein. The blotswere then alignedwith the poIy-
acrylamide gel, and the portion of the gel corresponding to the
immunoreactive band cut out, frozen at -70°C, lyophilized, and
injected weekly into mice with Freund's adjuvant. Three injections
of gel slices corresponding to those shown in Fig. 2 (lane 8 from
left) sufficed to elicit antibodies that reacted with endogenous
TCNA (Fig. 2, lane 4 from left). Similar results were obtained by
eliciting antibodies against the recombinant TCNA from clone 10C.
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Immunoblots. Endogenous TCNA was obtained by lysis of
trypomastigotes and epimastigotes in 0.01 M PBS, pH 7.0, con-
taining 1% Triton X-100 and protease inhibitors (5 PM pepstatin
and leupeptin, 10 mM EDTA, 5 mM iodoacetamide, and 10 gg/ml
soybean trypsin inhibitor), centrifuged at 1,000g to remove nuclei
and debri, and cleared at 100,000 g for 1 h. Amastigotes and
epimastigotes were treated similarly as trypomastigotes. Such ly-
sates (-10 ug/lane) were run on 10% SDS-PAGE, blotted to
nitrocellulose, and allowed to react with TCN-2 or 7F antibodies,
followed by an anti-mouse antibody conjugated to alkaline phos-
phatase, as previously described (6).
Recombinant TCNA was obtained from Escherichia coli XL1
Blue that hadbeen transformed with pBluescript containingTCNA
inserts (7F, 10C, 16C, 19Y, and 20G), or without inserts. Bacteria
were grown to an OD550 = 1.0, washed once with PBS, lysed
by freezing in liquid nitrogen in the presence ofprotease inhibitors
(see above) and thawing at 37°C for 15 min, and centrifuged in
a microfuge for 10 min. The supernatant was immediately ana-
lyzed by immunoblotting, sieving chromatography, or neuramini-
dase activity (see below). Preliminary experiments showed most
recombinant TCNA to be present in supernatants of the lysedbac-
teria and very little in bacterial pellets. It should be emphasized
that recombinant TCNA is highly susceptible to degradation, and
only fresh samples were analyzed. Even storage of the enzyme in
crude lysates at -20°C for several days gives rise to low mol wt
bands in the immunoblots and to reduced enzyme activity.
Sieving Chromatography.
￿
Supernatants (0.2 ml) from lysates of
bacteria transformed with 7F (prepared as above) were applied to
an Ultrogel AcA-22 (Pharmacia-LKB; Uppsala, Sweden) column
(40 x 1 cm) equilibrated with PBS at 4°Cthat had been calibrated
with dextran (void volume), thyroglobulin (660 kd), ferritin (440
kd), catalase (230 kd) and aldolase (158 kd). Aliquots (0.02 ml)
ofeach fraction (0.8 ml) were electrophoresed on 10% SDS-PAGE,
blotted to nitrocellulose, and probed with TCN-2, followed by an
alkaline phosphatase-conjugated goat anti-mouse IgG (6) . The
amount of immunoreactive material in the blots was quantitated
with a laser scanning densitometer.
Neuraminidase Activity.
￿
Lysates ofbacteria prepared as above were
analyzed for neuraminidase activity by hydrolysis ofthe fluorogenic
substrate 4MU-NANA as previouslydescribed (5, 6). Lysates were
also incubated with human erythrocytes and the degree ofcell de-
hydration ascertained by peanut lectin hemagglutination (12).
Library Construction and Screening.
￿
A tissue culture trypomas-
tigote (Silvio X-10/4) genomic DNA library was constructed in
AZAP by Stratagene (La Jolla, CA), after shearing and sizing of
the DNA to produce inserts of 4-9 kbp. The library was screened
unamplified with mouse polyclonalTCNA antibodies and TCN-2
mAb (see above) as described by Huynh et al. (15) . Clones 7F and
10C were isolated with the polyclonal antibody, and clones 16C,
19Y and 20G with TCN-2.
DNA Sequencing and Analysis.
￿
DNA inserts were automati-
cally excised and subcloned into pBluescript as recommended by
Stratagene. Clone 7F insert, despite being the largest of the iso-
lated inserts (Fig. 1 B), was chosen for DNA sequencing because
it consistently produced highest TCNA activity and a recombinant
protein that reacted the strongest with TCN-I, TCN-2 (Fig. 2),
and rabbit and mouse TCNA antibodies. Nucleotide sequence of
7F insert was determinedby the chain-termination method of Sanger
et al. (16) using double-stranded DNA as templates for T7 DNA
polymerase (United States Biochemicals [Cleveland, OH] and
Pharmacia-LKB [Uppsala, Sweden]) . 7F templates were obtained
by exonuclease III/Sl nuclease unidirectional digestion (17) starting
from the 3' end ofthe insert. Ambiguities and gaps were correctedby usingoligonucleotideprimersdesigned from previous sequences.
Nucleotide sequence of the other clones was determined in their
3'- and 5'-ends usingKS andSK primers(Stratagene), andin some
specifiedregions (see Fig. 1A), with oligonucleotideprimersbased
on the 7F sequence.
Sequenceswere analyzed on an AppleMacIntosh computer using
the DNAStriderprogram (18) or programs available from the Mo-
lecular Biology Computer Resource Center (MBCRR) at Dana-
Farber Cancer Institute, Harvard University (Boston, MA); and
from University ofWisconsin (Madison, WI)Genetics Computer
Group's sequence analysis software package (GCG) (19) (GCG use
was a courtesy of the GRASP Core Center at the New England
MedicalCenter, Boston, MA). Databases searched were Genbank
Release65, Protein Identification Resource Release25, andSwiss-
Prot-16. Optimalalignments between two sequences were deter-
mined with the FASTA program (20) . Statistical significance of
comparisons was computed with the program ALIGN (21).
RNA andDNA Blot Hybridization.
￿
Total RNA was prepared
from various developmental formsof T . cruzi and Vero cells using
LiCl/guanidinium isothiocyanate (22). RNA transfer wasperformed
as described (23) . Probes were derived from the coding region of
A
B
7F
2
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TCNA (fragment 2 was an Exo III/S1 deletion mutant equivalent
to by -92/537 and fragment 1 a Pst1/Pvu II digest of 7F, by
1800/3751; see Fig. 1 B and Fig. 3), labeled by random priming
(24), and hybridized under standard conditions. DNA (Southern)
blotswere performedexactly as describedby Sambrook et al. (23).
Markers for the RNA blot was the RNA ladder (BRL) and for
the DNA blot, a Hind III digest of phage X (New England Bi-
olabs, Beverly, MA).
Results
Isolation andNucleotide Sequence ofDNA Encoding TCNA.
Mouse polyclonal antibody against TCNA (6) was used as
a probe to screen a trypomastigote genomic DNA library
constructed in the AZAP expression vector. Approximately
105 clones from the unamplified library were screened, and
two immuno-reactive plaques containing N9.0- and 8.5-kb
inserts (7F and 10C, respectively) were isolated. Additional
clones (20G, 19Y and 16C) were isolated using the TCNA
specific mAb TCN-2 (6) (see Fig. 1 B).
Ps X
I 1
Ps X
Ps X
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Figure 1.
￿
Hydrophobicity plot of theTCNA sequence andschematicrepresentation oftheTCNA DNA. (A)Hydrophobicity oftheTCNA sequence.
The plot is colinear with the TCNA DNA sequence, and was generated according to Kyte and Doolittle (26). Positive values indicate hydrophobic
amino acids. The plot clearly shows thehydrophilic LTRand the hydrophobic segment in the C=terminus of TCNA, and the absence of N-terminal
peptide sequence. (B). Plasmids andDNA fragments used for sequencing and Northern and Southern blots. Heavy lines indicate the region of each
DNA clone that was sequenced. The fragments used for Northern and Southern blots are shown below the restriction map of 7F. Restriction sites
marked are: Pv, Pvu II; Ps, Pst I; X, Xho I.Inserts were subcloned into the plasmid Bluescript (pBlue)
and expressed in theE. coliXL1 Blue. By immunoblotting,
7F, 10C and 20G produced proteins (180 to 170 kD) that
were reactive with TCN-2 (Fig . 2 A) and with mouse (6)
and rabbit (5) polyclonal antibodies specific for TCNA (data
not shown) . These clones contain full-length copies of the
TCNA gene (Fig. 1) . Clone 16C, which has only part of
the TCNA gene (Fig . 1 B), displayed a band of 60 kd recog-
nized by the TCNA antibodies (Fig . 2 A) . Gel slices con-
taining the recombinant 7F protein were injected into mice
Figure 2 .
￿
Expression ofTCNA . (A) Immunoblot analysis of endogenous (left) and recombinant (right) TCNA . Lysates of trypomastigotes (tryp),
epimastigotes (epi), and amastigotes (aura) wereelectrophoresed in a 10% polyacrylamide gel, and probed with TCN-2 or anti-7F antibodies as indicated.
Lysates of E. coli transformed with TCNA clones 7F, 20G, 10C, and 16C, and with Bluescript alone were electrophoresed as above and probed with
TCN-2 . (B) Sieving chromatography on a Ultrogel AcA22 column of lysates ofE. coli transformed with 7F. The column was equilibrated with PBS
and run at 4°C . Aliquots (20 pl) of each fraction was electrophoresed on SDS-polyacrylamide gel, blotted to nitrocellulose, probed with TCN-2,
followed by alkaline phosphatase conjugated goat anti-mouse IgG. The amount of TCN-2 reactive material was quantitated with a laser scanning
densitometer. Arrows indicate the void volume (Vo), the estimated mw ofTCNA (660 Kd) and ferritin (440 Kd). (C) Neuraminidase activity of lysates
of E . coli transformed with Bluescript containing 7F (" ) or without insert (O) .
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trypomastigote lysates, giving a pattern similar to that pro-
duced by TCN-2 (Fig. 2 A). Sieving chromatography of 7F-
containingbacterial lysates, undernondenaturing conditions,
showed the TCN-2 immunoreactive material to have an ap-
parent ME of 660 kD (Fig. 2 B). Since the mol wt of the
7F monomer is 180 kD (Fig. 2 A), the 7F recombinant pro-
tein appears to be a trimer in its native state, consistent with
conclusions about the endogenous TCNA (Prioli, R.P., J.S.
Mejia, and M.E.A. Pereira, manuscript in preparation). Ly-
sates of bacteria transformed with 7F had neuraminidase ac-
tivity, as measured by their ability to hydrolyze a fluorogenic
substrate (Fig. 2 C) and to induce human erythrocytes to be
agglutinated by peanut lectin (data not shown) (12). Lysates
ofbacteria transformed with pBluescript alone did not have
detectableneuraminidase activity (Fig. 2 C). Similarly, plasmids
10C, 20G, and 19Y also induced neuraminidase activity in
E. coli (data not shown). Taken together, these findings es-
tablish that the clones isolated with the TCNA antibodies
encode the trypomastigote neuraminidase.
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The nucleotide sequence of7F contains a single long open
reading frame (ORF) starting with a methionine codon at
nucleotide 483 in a favorable context (7 out 13 nucleotides)
for translation initiation (25) and ends with a TGA stop codon
at nucleotide 3486 (Fig. 3). Nucleotides upstream of nt - 92
were derived from clone 19Y and all others from 7F. Methi-
onine codons are not found in-frame 5' of the putative start
site, and sequences upstream of the start site contain stop
codons in all three frames. The ORF encodes a protein of
1162 amino acids with a calculated mass of 119,959 daltons,
in contrast to the observed mol wt of 180 kD for the 7F
protein subunit as assessed by immunoblotting (Fig. 1 A) .
The apparent increase in size after SDS-PAGE and blotting
to nitrocellulose could be attributed to anomalous migration
of the protein due to a long tandem repeat (LTR) domain
(see below). The mass of the endogenous enzyme can be
slightly increased by glycosylation since there are only two
N-glycosylation sites (Fig. 3), which probably are glycosylated
in vivo because of a decrease of -5.0 kd in the mol wt of
TCNA polypeptides after digestion with N-Glycanase (10).
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Figure 3.
￿
DNA and predicted amino acid sequence of TCNA. Num-
bering of amino acids starts at the first in-frame methionine. The repeats
conserved in BNR are boxed, and the amino acids invariant in the con-
sensus sequence are circled. Cysteine residues are also circled, and poten-
tial N-glycosylátion sites are underlined and indicated by -CHO-. These
sequence data are available from EMBL/GenBank/DDBJ under accession
number R61732.Of the 8,885 nt of 7F only 5,404 are displayed in Fig. 3
because the remaining 3,481 nt in the 3'-end of the insert
contains an ORF of 1,061 nt that is transcribed in the three
stages ofT . cruzi (data not shown) . The deduced amino acid
sequence of this ORF is unrelated to TCNA . Details about
the remaining 3,481 nt of 7F will be published elsewhere .
Hydrophollicity and RNA Blot Analysis.
￿
Hydrophobicity
analysis (26) of TCNA does not reveal typical N-terminal
signal peptide sequences (Fig . 1 A) . Although most proteins
do contain a peptide leader sequence (27), TCNA is not unique
in lacking a signal peptide because several proteins such as
human IlJ1 (28) and bovine scavenger receptor (29) are syn-
thesized without a leader peptide. Therefore such peptide is
not an absolute requirement for proteins to be exported to
the surface or the environment .
Hydrophobicity analysis also illustrates a hydrophilicLTR
in the C-terminus, followed by a nonpolar region of35 amino
acids at the extreme C-terminus. This region is characteristic
of proteins anchored to the cell surface by a GPI linkage (30,
31), suggesting that TCNA is GPI-anchored to the trypo-
mastigote surface. This interpretation is consistent with
findings showing that TCNA is released spontaneously into
the culture medium (5) or by GPI-specific lipases (32) .
RNA blotting (Fig . 4) shows expression of the cloned gene
in trypomastigotes, epimastigotes, and amastigotes: three
major bands of 5 .3, 4.5, and 4.0 kb, and three minor bands
of 3.1, 2.8, and 2.4 kb hybridized to a probe derived from
the catalytic domain (Fragment 2, see Fig . 1 A) . Hybridiza-
tion was more intense with trypomastigotes than with epi-
and amastigotes, in accordance with immunoblot analysis (see
Fig . 2 A) and neuraminidase activity assays of the develop-
mental forms of T, cruzi (3, 4) . No hybridization was ob-
served with Vero cells RNA (Fig. 4) .
Primary Structure Analysis.
￿
The predicted protein sequence
of TCNA (Fig. 3) can be considered in four domains (Fig .
5) : (I) a N-terminal cysteine-rich region (residues 1-457) which
should contain the catalytic site of the enzyme ; (II) a
fibronectin (FN) type III module (residues 458-588) ; (II1)
a C-terminal long tandem repeat (residues 589-1127) ; and
(IV) a hydrophobic segment (residues 1128-1162) at the ex-
treme C-terminus.
Domain I: The Cysteine-Rich Region .
￿
The N-terminus of
TCNA contains six cysteine residues and exhibits 27% iden-
tity with the C. perfringens neuraminidase (33) in an align-
ment extending for about 90% of the bacterial enzyme (Fig .
6) . Support for the probablehomology between the cysteine-
rich domain ofTCNA and the C. perfringens neuraminidase
is provided by statistical analysis using the program ALIGN
(21), which gave a score of 10.33 standard deviations above
the mean obtained by 100 random permutations of the two
sequences . The TCNA domain includes three consensus se-
quences (X-X-S-X-D-X-G-XTWX-X) (Figs . 3 and 6) which
are highly conserved in bacterial and viral neuraminidases (34) .
These bacterial neuraminidase repeats (BNR) are located in
separate regions of TCNA, similar to their distribution
in bacterial neuraminidases (34) . Because of its structural
similarity with the C. perfringens neuraminidase and with the
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Figure 4 .
￿
RNA blot analysis ofTCNA transcripts . TotalRNA (30,ug)
was separated on a 1.2% agarose-formaldehyde gel, blotted to a nylon mem-
brane, and probed with fragment 2 (Fig. 1 B) derived from the catalytic
domain, which was labeled with 32P by random priming. RNA sources
were : trypomastigotes (lane A), epimastigotes (lane B), amastigotes (lane
C), and Vero cells (lane D) .
Figure 5 .
￿
Schematic model of the predicted monomeric structure of
TCNA . ((D),BNR repeats; (40)YWTD repeats ; (-<), N-glycosylation
sites ; (0), type III module; (-{-++), LTR domain .
N
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Cysteine-rich
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Figure 6.
￿
Alignment of the N-Terminus domain of TCNA with the
C. perfringens neuraminidase. Identities are marked by vertical lines and
conservative substitutions (DE; K,R; L,I,V M,C; Y,FW; ST) by colons.
Gaps are indicated by (-).
BNR motifs, the rysteine-rich domain is assumed to contain
the catalytic site of the enzyme.
The rysteine-rich domains also includes two motifs ho-
mologous to the YWTD repeats present in the LDL receptor
(35), the LDIrrelated lipoprotein receptor (36),the epidermal
growth factor (EGF) precursor (37), the basement membrane
protein nidogen (38), and the sevenless protein (a tyrosine
kinase) of Drosophila (39) . Five and four consensus residues
of the YWTD module are aligned in the two TCNA repeat
sequences, respectively (Fig. 7), compared to four in module
E of the LDL receptor, and eight and seven in modules A
and B of sevenless (reference 39; see Fig. 7). The YWTD
repeats of TCNA were discovered by scanning protein data
bases with the rysteine-rich domain usingFASTA (20), which
revealed 34% identity between residues 184-230 of TCNA
and residues 1465-1511 of sevenless, which were proposed
to form a YWTD motif (39).
The domain has 10 potential protein kinase substrate sites
(40): 4 for the cGMP-dependent protein kinase (XSRX;
residues 40-43, 46-49, 70-73, and 225-228), 1 for the S6
kinase (XRXXSX; residues 448-453), 1 for casein kinase II
(XSXXSX; residues 231-236), and 4 for the glycogen syn-
thase kinase (XSXXXSX; residues 11-17, 66-72, 72-78, and
334-340). One N-glycosylation site separates the BNR and
YWTD like repeats from the next domain, the FNIII module
(Figs. 3 and 5).
Domain Ib The FNIIIModule
￿
FNIII modules were defined
originally as segments of 71-109 amino acids repeated 15 times
in fibronectin (41). Their characteristics include conservation
ofcertain aromatic residues and adjacent hydrophobic amino
acids at defined positions, with no conserved cysteines (39,
41). Sequence similarityamong the fibronectin modules ranges
from 5 to 39% (41). Sequences similar to FNIII repeats were
subsequently found in other vertebrate proteins including
cytotactin (42), contactin (43), leukocyte common antigen-
related protein LAR (44), the neural adhesion molecule
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Figure 7.
￿
Alignment ofthe TCNA repeats with'YWTD'motifs from
human LDL receptor, epidermal growth factor precursor, and sevenless
protein. Sequences for the human LDL receptor (LdIR) and epidermal
growth factor precursor (EgfP) and sevenless were taken from Norton et
al. (39), as was the consensus element, which was derived by the align-
ment of 55 YWTD repeats. Amino acid residues for the TCNA YWTD
motifs A and B are 54-92 and 189-220, respectively.
N-CAM (45), tenascin (46), growth hormone/prolactin
receptors (47), and in the invertebrate proteins fascilin II (48)
and the sevenless gene product (39).
Consensus sequences for the FNIII repeats present in hor-
mone receptors (reference 47; Receptor in Fig. 8), sevenless
protein (reference 39; Sevenless in Fig. 8), and fibronectin,
LAR and tenascin (reference 39; FN in Fig. 8) have been de-
rived by multiple alignment programs. Comparison of the
three consensus sequences with TCNA segment 458-588,
which is devoid of cystine residues, reveals conserved aromatic
residues (tryptophan and tyrosine; denoted by 0 in Fig. 8)
and nearby hydrophobic residues (highlighted by (*) in Fig.
8): 7 of 16 residues typical of the sevenless protein type III
module are conserved in the TCNA sequence. Relatedness
of TCNA with the fibronectin type III repeat was initially
detected by scanning the Protein Identification Resource and
Swiss-Prot data bases with the program FASTA (20).
The FNIII domain has 1 BNR motif (residues 469-480)
and 5 recognition sites for protein kinases (40): 3 for proline-
dependent protein kinase (XTPX; residues 482-485, 487-490,
and 531-534), 1 for casein kinase II (XSXXEX; residues
470-475), and 1 for glycogen synthase kinase (XSXXXSX;
residues 457-462).
The domain also contains three stretches of amino acid
sequences, G-S-WETG-K (residues 491-497), D-Irl-G (res-
idues 580-583), and N-K-I-G (residues 497-500), that fit (with
one amino acid mismatch) the consensus elements required
for GTP-binding proteins: G-X-X-X-X-G-K, D-X-X-G, and
N-K-X-D (49, 50). A fourth additional consensus sequence,
E-X-S-A, required by ras and ras-related proteins for GTP-
binding (51), is present in domain I (residues 293-296, E-N-
S-A). However, while the order and spacing of two of the
GTRbinding motifs correctly match with TCNA sequence,
two do not.
Domain IIL. The Long Terminal Repeat.
￿
Contiguous to the
FNIII module is a stretch of 535 amino acids composed of
44 units of 12 amino acids, plus a degenerate unit of 7 amino
acids in the C-terminus of the LTR. The truncated unit con-
tains one potential N-glycosylation site separating LTR from
the hydrophobic segment (Domain IV, see Figs. 3 and 5).
LTR constitutes almost half (46%) of the entire TCNA se-Figure 8.
￿
Alignment ofTCNA (res-
idues 458-592) with sequence motifs
from fibronectin type III domains. Con-
sensus sequenceswere derived from type
III repeats found in fibronectin (FN)
(39), growth hormone/prolactin re
ceptors (Receptor) (47), and sevenless (39). Conserved hydrophobic residues are marked by asterisks, aromatic residues by 0, and amino acids conserved
in at least one the three consensus sequences are underlined.
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quence. Each unit is rich(75%) in serine, threonine and pro-
line, with a consensus sequence (D-S-S-AH-XTP-STP-X)
remarkably conserved in the entire LTR domain (Fig. 9).
The LTRdomain is predicted to be very hydrophilic (Fig.
1 A) because of its high content (75%) of polar and charged
amino acids (serine, threonine, aspartic acid and histidine).
The domain contains the motif XTP-X, which is a recogni-
tion sequence for the proline-dependent protein kinase (40),
repeated twice in each unit (except unit 9 in which one TIP
is replaced by AP) and thus 87 times in LTR, and the motif
X-S-XX-XS-P-X, a substrate for glycogen synthase kinase,
is repeated 30 times. The domain therefore contains at least
117potential phosphorylation sites. When the LTR domain
was compared with proteins in the Protein Information Re-
source and Swiss-Prot data bases using PASTA (20), best
similarity was with the carboxyl-terminal domain of the mouse
RNA polymerase II largest subunit, which consists of 52
repeats of seven amino acid blocks rich in serine, threonine
and proline (52); and the serines from the repeats are phos-
phorylated in vivo by kinase such as cdc2 (53).
To determine whether LTRis polymorphic or not, genomic
DNA from T. cruzi Silvio X-10/4 was digested with Pvu II
and Pst I enzymes (whose recognition sites are uniquely
flanking the 5'- and 3'- ends of the domain, respectively, see
Fig. 1 B), electrophoresed in 1% agarose and analyzed by
Southern blotting using 32P-labeled fragment 1 DNA de-
rived from the repeat. At least seven bands (3.7 to 0.6 kb)
hybridized to fragment 1 (Fig. 10) suggesting that LTR has
variable lengths within the T. cruzi genome, which couldac-
count in part for the polymorphism of the TCNA protein
(Fig. 2 A).
Domain IV The Hydrophobic Segment.
￿
A functionally un-
related group of at least 30 proteins is known to be attached
to the plasma membrane by a GPI lipid anchor (30-32). A
common feature among these proteins is the presence of a
hydrophobic domain in their C-terminus, which is proteo-
lytically processed in the endoplasmic reticulum to be replaced
by the GPI anchor. TCNA contains a stretch of 35 amino
acids at the extreme C-terminus (Figs. 1 B, 3, and 5), raising
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the possibility that it is anchored to the outer membrane by
a GPI mechanism. This is likely to be the casebecause TCNA
from tissue culture trypomastigotes can be released into the
supernatant by digestion with phosphatidylinositol-specific
phospholipase C (PIPLC), an enzyme that cleaves the GPI
anchor specifically (31, 32). If so, the hydrophobic segment
of TCNA must be processed to allow insertion of the GPI
and thus it must be absent from the mature enzyme located
on the trypomastigote surface. Although the C-terminus of
GPI-anchored proteins contains information required for at-
tachment of the anchor, the nature ofand consensus sequence
for the signal that directs processing of hydrophobic tails is
unknown. Therefore it remains to be determined if residual
amino acids from the hydrophobic segment will bridge the
LTR domain to the GPI anchor.
Discussion
Neuraminidases catalyze the hydrolysis of sialic acid from
glycoconjugates in solution or on cell membranes and are
widely spread in vertebrates, where they perform important
functions such as in reproduction and blood clot formation
(54, 55). Their absence in humans causes inborn error me-
tabolism (56) . They are absent from invertebrates and plants
but present in some microorganisms, in particular in those
that are pathogenicto vertebrates (54). However, many para-
sites do not have detectable enzyme activity.
The neuraminidase from influenza virus was the first to
be cloned and it remains one of the best studied proteins,
and much is known about its crystal structure, structure-
function relationships, antigenicity, and role in viral entry
and exit from host cells (57). The genes for several bacterial
neuraminidases have been cloned and characterized in the last
three years (34, 58), and progress abouttheir structure-function
relationships is anticipated in the near future. In contrast,
nothing is known about the primary structure of protozoan
neuraminidases and, surprisingly, of vertebrates, including
man. The sequence and domain structure ofTCNA presented
here is therefore the first for a neuraminidase derived from
eukaryotes.
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Amino add sequence ofthe
LTR . domain of TCNA. Numbers to
the left refer to positions within the re-
peat and numbers on the top refer to
the number ofthe repeat. The only vari-
able positions are 6 and 12, except re-
peat 9, in which A replaces T in posi-
tion 7.
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Southern blot oftheLTR domain ofTCNA . Trypomastigote
genomicDNA (Silvio X-10/4) was digested with Pvu 11 and Pst 1, elec-
trophoresed on1% agarose gel, transferred to a nylon membrane and probed
with 3 2P-labeled fragment 1 (Fig . 1 B) from the LTR domain.
Cysteine-Rich Domain. TCNA has structural features
shared by other neuraminidases, the most striking of which
is the presence ofrepeats conserved in bacterial and viral neur-
aminidases. All bacterial neuraminidases whose primary se-
quence is known have four repeats of consensus X-X-Ser-X-
Asp-X-GIy-XThr-Trp-X-X, which are spaced from one an-
other by 40-80 residues (34) . TCNA also has four suchBNRs
(three in domain I and one in domain II) (Figs . 6 and 8) with
consensus spacings similar to those in bacterial enzymes. In
addition, domain I ofTCNA is about 30% identical in se-
quence to the C. perfringens neuraminidase with an ALIGN
score of 10.33 standard deviations above the mean, supporting
the argument that TCNA domain I and the C . perfringens
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enzyme are homologous to one another. TCNA, like the
C . perfringens enzyme, does not havecommon amino acid se-
quence with bacterial neuraminidases, except for the BNRs .
TCNA has structural motifs which are unique when com-
pared to other neuraminidases . In the cysteine-rich domain
there are two repeats similar to the YWTD motifs found
in vertebrate and invertebrate proteins. Little isknown about
their function, but mutagenesis of theYWTD repeats and
flanking cysteine-rich motifs of the LDL receptor produces
mutant receptors unable to bind LDL, to release (3VLDL
at acid pH, and to recycle properly (59) . It is of interest that
HDL and LDL are specific inhibitors ofTCNA activity (7,
8), and that binding of 1251-HDL to the developmental
forms ofT . cruzi correlates with TCNA activity, suggesting
that TCNA can serve as receptors for lipoproteins. If so, it
could be that theYWTD motifs of TCNA are involved in
binding to host lipoproteins .
FNIII Domain.
￿
The FNIII motifofTCNA connects the
cysteine-rich domain toLTR (Fig. 5) . Like theYWTD repeats,
FNIII molecules have not been previously observed in microor-
ganisms . They are found in multiple copies in several develop-
mentally regulated proteins that participate in activities such
as binding to cell surface integrins and to heparin . It is there-
fore possible that the FNIII domain contributes to TCNA
binding to host cell-surface proteins during T . cruzi-host cell
interactions . This hypothesis is consistent with the altera-
tion of T . cruzi infection by TCNA antibodies (5, 6) . Alter-
natively, the FNIII domain could mediate TCNA binding
to endogenous T . cruzi proteins to form ligand-enzyme com-
plexes. This hypothesis is in keeping with recent findings
which reveal a protein of 110-115 kd that co-precipitates with
TCNA during immunoprecipitation with monoclonal anti-
bodies specific for the T . cruzi enzyme but not with isotype-
matched control antibodies (Mejia, J.S.,R.P. Prioli, E . Ortega-
Barria, and M.E.A . Pereira, unpublished observations) .
Nucleotide binding consensus motifs have been derived by
sequence comparison of many functionally distinct GTR
binding protein families (49-51) . The importance of these
motifs was confirmed by the X-ray structure of the GTP-
binding domain of the elongation factor Tu (60) and of ras
protein (61) . These studies showed that the motifs GXX
XXGK and DXXG, separated from one another by 40-80
amino acids, are involved in binding to phosphate of GTP,
whereas the motifNKXD mediates interaction with the keto
group ofthe guanine ring. The FNIII module ofTCNA con-
tains the phosphate binding motifs in correct spacing and
order (residues 491-497 and 580-583 ; respectively), and, al-
though it contains the guanine-ring binding motifs (residues
497-500 and 293-296), they are not spaced properly. Thus,
although it is unlikely that the FNIII domain binds GTP,
the conservation ofGXXXXGK and DXXG raises the in-
triguing possibility that TCNA binds phosphate, either as
sugar-phosphate or as nucleotides (other than GTP) .
LTR Domain.
￿
TheLTR domain is unique among known
neuraminidases, but it is a common feature of parasitic pro-
tozoan proteins whose primary structures are known (62) .
Proteins with long tandem repeats usually have anomalous
migration inSDS-PAGE, and thedifferences between the valuepredicted by DNA sequence and the one obtained experimen-
tally can vary by as much as 100% (62). The LTR domain
helps therefore explain the discrepancy between the predicted
mol wt of TCNA (119,959 kD) and the one observed by
immunoblotting of recombinant TCNA (180,000 kD).
The function of LTRs in protozoan proteins has not been
elucidated, but it has been suggested that tandem motifs, due
to their intrinsic repeated structure and consequent enhanced
immunogenicity, may form a "smokescreen" against the host
immune response to protect domains involved in functions
such as in binding to host cellsor catalytic activity (62) . This
could well be the case for TCNA, because the repeat unit
of LTR contains epitopes for monoclonal and polyclonal an-
tibodies raised against the intact enzyme. For example, we
have found that binding of the mAb TCN-2 to TCNA is
competitively inhibited by the soluble synthetic peptide Asp-
Ser-Ser-Ala-His-GlyThr-Pro-Ser-Thr-Pro Val, that is repeated
many times in LTR, and that TCN-2 and Chagasic sera bind
to the peptide coupled to a protein carrier (ovalbumin) (Prioli,
R.P., E. Ortega-Barria, J.S. Mejia, and M.E.A. Pereira, un-
published observations). TCN-2 epitopes present in the
C-terminus is consistent with the finding that the antibody
neutralizes desialylation of erythrocytes but not of soluble
small molecules (6). We have not yet found antibodies, mono-
clonal or polyclonal that react with synthetic peptides from
domain I (Fig. 5) or with the intact domain.
The amino acid composition of LTR contains a high con-
tent of a-helix- and (3-sheet-breaking amino acids (serine,
threonine, and proline) in invariant positions (Fig. 9) (63).
Empirical predictive methods indicate that the probability
of a-helix and (3-sheet is less than 1%, and for (3-turn more
than 99% (64). TCNA may belong to a group of proteins
such as RNA polymerase II and rhodopsin, that contain
tandem repeats having 20-60% Pro with abundant Gly, Gln,
and Ser, which can give rise to a novel secondary structure,
polyproline 0-turn helix (65). Many of these structures are
consistent with a series of turns in an extended conformation.
LTR is similar to the C-terminal sequence of shed acute
phase antigen (SAPA) of T. nuzi, which contains tandem units
of 12 amino acids rich in Ser, Thr, and Pro, ending with a
hydrophobic segment (66). SAPA has only 14 tandem repeats,
compared to 44 for TCNA. The N-terminus sequence ofSAPA
is now known, and it is about80% identical to that of TCNA
(A.C.C. Frasch, personal communication). It is of interest
that TCNA activity was detected in the serum of a patient
accidentally infected with T. cruzi, but only in the acute phase
of Chagas' disease (67). Since TCNA activity was present
before noticeable parasitemia, neuraminidase activity assays
were proposed to serve as an aid for the diagnosis of acute
Chagas' disease, similar to what has been suggested for SAPA
(66) . SAPA and corresponding antibodies also appear to be
extremely useful reagents to confirm congenital cases of
Chagas' disease (68). Although it is not yet known whether
SAPA has neuraminidase activity, it is possible that it belongs
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to the TCNA family. Differences in their sequences could
be attributed to strain variations, to the fact that the TCNA
and SAPA sequence were derived from trypomastigote and
epimastigote genomes, respectively, or to isoform variations.
TCNA Polymorphism.
￿
TCNA from tissue culture trypo-
mastigotes is comprised ofa set of high mol wt polypeptides
that differ in size and number according to strains and clones
of T. cruzi. Within a given cloned T. cruzi strain, the size
ofthe polypeptides may vary by more than 80 kd (5, 6). The
mechanism underlying such polymorphism is not clear, but
postranslational modifications may not be one them because
pulse-chase experiments failed to show a time-dependent in-
terrelationship in the generation of the polypeptides (Mejia,
J.S., E. Ortega-Barria, R.P. Prioli, and M.E.A. Pereira, un-
published observations). Alternatively the polypeptides could
arise from distinct TCNA genes or by cotranslational modi-
fications: RNA blots hybridized with DNA derived from
the catalytic domain (Fragment 2, Fig. 1 B) show at least
7 bands (Fig. 4). Southern blotting experiments using DNA
from the LTR domain as a probe, and genomic DNA digested
with Pvu 11 and Pst 1, that cut the repeated structure in its
5' and 3' ends, respectively (Fig. 1 A), reveal a multiple banding
pattern. Thus, Southern blotting results are consistent with
the notion that variable length polymorphism of the LTR
DNA is a mechanism for the multiple banding of TCNA
polypeptides.
TCNA polymorphism can also be rationalized on the basis
ofprotein synthesis initiation at different methionine codons.
Proteins can be synthesized from overlapping reading frames
if the first AUG codon does not lie in an optimum context
for ribosomal subunit recognition, such as with many viral
proteins (69). Assuming that the initiationsignal form high
eukaryotes (GCCGCCAGCCAUGG) holds for T. cruzi, the
first AUG codon of TCNA is in a good but not perfect con-
text (7 out of 13 nucleotides). If the ribosomal subunit by-
pass the first AUG, it may stop and initiate protein synthesis
at the next in-frame AUG (residues 364-366), which is an
even better context (8 out of 13 nucleotides). And it is pos-
sible that some TCNA isoforms contain AUG initiation codon
upstream of the one shown in Fig. 3 . But whatever the mech-
anism for the polymorphism of TCNA may be, it does not
seem to abolish enzyme activity since each polypeptide from
Silvio X-10/4 (Fig. 2 A) exhibits neuraminidase activity after
isolation by sieving chromatography under nondenaturing
conditions (Prioli, R.P., J.S. Mejia, and M.E.A. Pereira, manu-
script in preparation) .
In conclusion, the structure of TCNA as deduced from
DNA sequence suggests that the enzyme, in addition to
catalyzing hydrolysis of sialic acid from glycoconjugates, may
have other important functional properties, including Protein-
protein interactions and binding to nucleotides. The avail-
ability of TCNA DNA clones provides experimental tools
that should be useful in further dissecting the structure and
function of the enzyme.References
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